** Shares in Amplifon AMPF.MI fall as much as 14.9% at 10.27 euros, their lowest price since March 2017, after posting a 7.9% yearly drop in its Q4 net profit with few signs of recovery
** The stock is currently the second-worst performer on the Stoxx 600 index .STOXX
** The co says it now expects an adjusted EBITDA margin improvement at the high end of the previously disclosed 150–200 basis-point range by 2027
** "Guidance is only qualitative at this stage and likely off a lower base than consensus was expecting on both an organic basis," J.P. Morgan notes, adding the quarterly release rounds out a disappointing year for the firm
** "We think that the risk/reward is very skewed to the upside," adds broker Equita, seeing still no signs of recovery in the organic top-line in Q4 and few factual elements in calls to support the recovery
** If losses hold, the stock is on track for its worst day since July 30, 2025
(Enrico Sciacovelli)
((Enrico.sciacovelli@thomsonreuters.com))